Forrest, Shelley L.
Lee, Seojin
Nassir, Nasna
Martinez-Valbuena, Ivan
Sackmann, Valerie
Li, Jun
Ahmed, Awab
Tartaglia, Maria Carmela
Ittner, Lars M.
Lang, Anthony E.
Uddin, Mohammed
Kovacs, Gabor G. http://orcid.org/0000-0003-3841-5511
Funding for this research was provided by:
Rossy Foundation
Edmond J. Safra Philanthropic Foundation
Sandooq Al Watan grant (F2018-002)
National Health and Medical Research Council of Australia Ideas grant (214090508)
Canada Foundation for Innovation (40480)
National Institute on Aging of the National Institutes of Health (R01AG080001)
Macquarie University
Article History
Received: 7 May 2023
Revised: 11 June 2023
Accepted: 16 June 2023
First Online: 24 June 2023
Declarations
:
: AEL has served as an advisor for AbbVie, AFFiRis, Alector, Amylyx, Aprinoia, Biogen, BioAdvance, BlueRock, Biovie, BMS, CoA Therapeutics, Denali, Janssen, Jazz, Lilly, Novartis, Paladin, Pharma 2B, PsychoGenetics, Retrophin, Roche, Sun Pharma, and UCB; received honoraria from Sun Pharma, AbbVie and Sunovion; received grants from Brain Canada, Canadian Institutes of Health Research, Edmond J Safra Philanthropic Foundation, Michael J. Fox Foundation, the Ontario Brain Institute, Parkinson Foundation, Parkinson Canada, and W. Garfield Weston Foundation; is serving as an expert witness in litigation related to paraquat and Parkinson’s disease, received publishing royalties from Elsevier, Saunders, Wiley-Blackwell, Johns Hopkins Press, and Cambridge University Press. GGK is member of the Acta Neuropathologica Editorial Board but was not involved in the editorial handling of this article. GGK has served as an advisor for Biogen; received royalty for 5G4 synuclein antibody and publishing royalties from Wiley, Cambridge University Press and Elsevier, received grants from Edmond J Safra Philanthropic Foundation, Rossy Foundation, Michael J. Fox Foundation, Parkinson Canada, Canada, Canada Foundation for Innovation, MSA Coalition, and National Institutes of Health (NIH). SLF, SL, NN, IMV, VS, JL, AA, MCT, LI, MU have no declarations of interest.